1,188 results on '"Stiff P"'
Search Results
202. Keeping the Feast: The Socializing Dynamics of the Eucharist, 1 Corinthians 11:17-34, and Enabling Boundaries for Individuals with Disabilities#
203. A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma
204. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections
205. Stable transformation of barley callus using biolistic® particle bombardment and the phosphinothricin acetyltransferase (bar) gene
206. Disability: Living into the Diversity of Christ’s Body
207. Giant mature cyst formation following mesh repair of hernias: An underreported complication?
208. Management of the adverse effects associated with intravenous bisphosphonates
209. Stably transformed callus of wheat by electroporation-induced direct gene transfer
210. Improvement of anther culture methods for doubled haploid production in barley breeding
211. 21. New Immunological Principles: 115 RESULTS FROM A PHASE I/II STUDY OF GALIXIMAB (ANTICD80) IN COMBINATION WITH RITUXIMAB (ANTI-CD20) FOR RELAPSED OR REFRACTORY, FOLLICULAR NHL
212. Palifermin (recombinant human keratinocyte growth factor) reduces severe oral mucositis in patients with haematological malignancies undergoing autologous peripheral blood progenitor cell transplantation: a combined analysis of phase 2 and 3 data
213. Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine 131I tositumomab)
214. Number of failed organs and response to therapy determine outcome in patients with acute pancreatitis requiring level 1 organ support
215. When to CHEUS Contrast-Enhanced Endoscopic Ultrasound to Assess Gallbladder Wall Thickening
216. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood
217. Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model
218. A Call for Evidence-Based Conservative Management of Nail Unit Malignancies
219. Pilot Trial of Interleukin-2 With Granulocyte Colony-Stimulating Factor for the Mobilization of Progenitor Cells in Advanced Breast Cancer Patients Undergoing High-Dose Chemotherapy: Expansion of Immune Effectors Within the Stem-Cell Graft and Post–Stem-Cell Infusion
220. Prospective randomised study comparing tacrolimus (Prograf) and cyclosporin (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases
221. Pancreatic inflammatory pseudotumour: an uncommon childhood lesion mimicking a malignant tumour
222. Fourier Transform Infrared Absorbance and Photoluminescence Spectroscopy Studies of CdSe Colloidal Quantum Dot/Conducting Polymer Nanocomposites for Application to Infrared Photodetectors
223. Solitary rectal ulcer syndrome – an underdiagnosed condition
224. Conversion from cyclosporin to tacrolimus in a patient with prolonged acute tubular necrosis
225. Optical Characterization of CdSe Colloidal Quantum Dot/ MEH-PPV Polymer Nanocomposites Spin-Cast on GaAs Substrates
226. Expanding the Toolbox of Adoptive Cell Immunotherapy.
227. Motixafortide Enables Consistent, Robust Hematopoietic Stem Cell Collection (HSC) across Populations with Increased Impaired HSC Mobilization: A Sub-Group Analysis of the Genesis Study
228. Omidubicel-Onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies: Results of a Multicenter Open-Label Expanded Access Program (EAP)
229. Dose-Response Demonstrated for Durable Complete Remission Following High-Dose Targeted Radiation with 131I-Apamistamab Prior to HCT in Patients with R/R AML
230. 131I-Apamistamab-Led Allogeneic Hematopoietic Cell Transplant for Patients with TP53 Mutated R/R AML Results in Significantly Improved Outcomes
231. Targeted Myeloablative Radiation Using 131I-Apamistamab Prior to Allogeneic Hematopoietic Cell Transplant for Patients with R/R AML Results in Robust Engraftment
232. 131I-Apamistamab Improves Outcomes in Patients 65 Years and Older with Relapsed or Refractory AML
233. Does the surgeon still have a role to play in the diagnosis and management of lymphomas?
234. Post coital aortic dissection: a case report
235. Quantum Dot Long-Wavelength Detectors
236. Internal jugular vein thrombosis in a warfarinised patient: a case report
237. Determining client need in a multi-state fetal alcohol syndrome consortium: from training to practice
238. Cholecystokinin Provocation HIDA test
239. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions
240. Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6
241. Leiomyosarcoma of the inferior vena cava: Clinical experience with four cases
242. Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study
243. A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies
244. Determining the optimal time interval for cholecystectomy in moderate to severe gallstone pancreatitis: A systematic review of published evidence.
245. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
246. An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer
247. Examining Opportunities for Mobility for Professional Staff in State Universities.
248. 'Come to Think of It...:' Interrogative Probes, Deceptive Communication, and Deception Detection.
249. Empathy, Communication, and Prosocial Behavior.
250. Predictors of Horror Film Attendance and Appeal: An Analysis of the Audience for Frightening Films.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.